An analytical model to predict the cost-effectiveness of long-term eszopiclone for the treatment of primary insomnia

被引：0
|
作者：
Snedecor, S. L. [1 ]
Botteman, M. F. [1 ]
Schaefer, K. [2 ]
Barry, N. [2 ]
Rubens, R. [2 ]
Pickard, A. S. [3 ]
机构：
[1] Pharmerit N Amer, Bethesda, MD USA
[2] Sepracor Inc, Marlborough, MA USA
[3] Univ Illinois, Coll Pharm, Chicago, IL USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65345-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A381 / A382
页数：2
相关论文
共 50 条
  • [1] Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults - A decision analytical model
    Botteman, Marc F.
    Ozminkowski, Ron J.
    Wang, Shaohung
    Pashos, Chris L.
    Schaefer, Kendyl
    Foley, Daniel J.
    [J]. CNS DRUGS, 2007, 21 (04) : 319 - 334
  • [2] Cost Effectiveness of Long-Term Treatment with Eszopiclone for Primary Insomnia in AdultsA Decision Analytical Model
    Marc F. Botteman
    Ron J. Ozminkowski
    Shaohung Wang
    Chris L. Pashos
    Kendyl Schaefer
    Daniel J. Foley
    [J]. CNS Drugs, 2007, 21 : 319 - 334
  • [3] Cost-effectiveness of eszopiclone for the treatment of adults with primary insomnia
    Snedecor, S. J.
    Botteman, M. F.
    Schaefer, K.
    Barry, N.
    Pickard, A.
    [J]. SLEEP, 2008, 31 : A246 - A246
  • [4] Cost-Effectiveness of Eszopiclone for the Treatment of Adults with Primary Chronic Insomnia
    Snedecor, Sonya J.
    Botteman, Marc F.
    Bojke, Chris
    Schaefer, Kendyl
    Barry, Nadine
    Pickard, A. Simon
    [J]. SLEEP, 2009, 32 (06) : 817 - 824
  • [5] Cost-effectiveness of eszopiclone for the treatment of adults with primary insomnia in the US
    Bell, C.
    Snedecor, S. J.
    Botteman, M. F.
    Schaefer, K.
    Pickard, A. S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 305 - 305
  • [6] Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: A decision analytical model. (vol 21, pg 319, 2007)
    Botteman, M. F.
    Ozminkowski, R. J.
    Wang, S.
    Pashos, C. L.
    Schaefer, K.
    Foley, D. J.
    [J]. CNS DRUGS, 2007, 21 (05) : 405 - 405
  • [7] Cost-effectiveness of longer-term treatment with eszopiclone 3mg in adults with primary insomnia
    Botteman, M
    Ozminkowski, R
    Wang, S
    Pashos, CL
    Foley, DJ
    Schaefer, K
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 323 - 323
  • [8] WEIGHT CHANGES IN PATIENTS WITH PRIMARY INSOMNIA FOLLOWING LONG-TERM ESZOPICLONE TREATMENT
    Krystal, A.
    Cooper, J.
    Schaefer, K.
    Friedman, M.
    Roth, T.
    [J]. SLEEP, 2009, 32 : A280 - A281
  • [9] Long-term cost-effectiveness of weight management in primary care
    Trueman, P.
    Haynes, S. M.
    Lyons, G. Felicity
    McCombie, E. Louise
    McQuigg, M. S. A.
    Mongia, S.
    Noble, P. A.
    Quinn, M. F.
    Ross, H. M.
    Thompson, F.
    Broom, J. I.
    Laws, R. A.
    Reckless, J. P. D.
    Kumar, S.
    Lean, M. E. J.
    Frost, G. S.
    Finer, N.
    Haslam, D. W.
    Morrison, D.
    Sloan, B.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (06) : 775 - 783
  • [10] Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
    Sroczynski, G.
    Esteban, E.
    Conrads-Frank, A.
    Schwarzer, R.
    Muehlberger, N.
    Wright, D.
    Zeuzem, S.
    Siebert, U.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 34 - 50
12345